Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Four Week, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2A Study Of PH-797804 In The Treatment Of Post-Herpetic Neuralgia

NCT00614705 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00614705
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00614705 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Four Week, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2A Study Of PH-797804 In The Treatment Of Post-Herpetic Neuralgia
Lead sponsor
Pfizer
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2008
Completion date
December 31, 2008
Enrollment
80 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

neuralgia, postherpetic